60 Degrees PharmaceuticalsSXTP -2.29%44 Days Inventory is 831.86 as of Mar. 2026, which is 106% above its 10-year median of 404.67. GuruFocus rates SXTP with a GF Score™ of 44/100 and a GF Value™ of $2.05 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 638 Biotechnology companies, 60 Degrees Pharmaceuticals ranks worse than 71.94% on this metric.
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
60 Degrees Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.11.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
60 Degrees Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 4.84.
60 Degrees Pharmaceuticals (NAS:SXTP) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
60 Degrees Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
60 Degrees Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
60 Degrees Pharmaceuticals Days Inventory Related Terms
60 Degrees Pharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SXTP vs GLMD, FBLG, CELZ: Days Inventory Comparison
For the Biotechnology subindustry, 60 Degrees Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
60 Degrees Pharmaceuticals Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 60 Degrees Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where 60 Degrees Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
60 Degrees Pharmaceuticals (SXTP) has a Days Inventory of 831.86 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on 60 Degrees Pharmaceuticals and its competitors. This is 106% above median its historical median of 404.67. Over the past decade, 60 Degrees Pharmaceuticals' Days Inventory has ranged from 257.04 to 539.97. According to the industry distribution chart, 60 Degrees Pharmaceuticals ranks #459 out of 638 companies in the Biotechnology industry, placing it in the top 71.9%.
Is 60 Degrees Pharmaceuticals' Days Inventory too high?
60 Degrees Pharmaceuticals' current Days Inventory of 831.86 is 106% above median its 10-year median of 404.67. Over the past 10 years, this metric has ranged from a low of 257.04 to a high of 539.97. The Biotechnology industry median Days Inventory is 183.88. 60 Degrees Pharmaceuticals' value of 831.86 is 352.4% above this industry median. Based on the distribution chart, 60 Degrees Pharmaceuticals ranks #459 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, 60 Degrees Pharmaceuticals has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does 60 Degrees Pharmaceuticals' Days Inventory compare to GLMD and FBLG?
According to the Biotechnology industry distribution chart, 60 Degrees Pharmaceuticals ranks #459 out of 638 companies for Days Inventory. This places 60 Degrees Pharmaceuticals in the lower half of its industry. The industry median Days Inventory is 183.88. 60 Degrees Pharmaceuticals' value of 831.86 is 352.4% above this benchmark. Historically, 60 Degrees Pharmaceuticals' own Days Inventory has ranged from 257.04 to 539.97 over the past decade. While the company's 10-year median is 404.67 vs. the industry median of 183.88, 60 Degrees Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 60 Degrees Pharmaceuticals's current Days Inventory of 831.86 is 352.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on 60 Degrees Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 60 Degrees Pharmaceuticals's current Days Inventory is 831.86, which is 106% above median its own 10-year median of 404.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 60 Degrees Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, 60 Degrees Pharmaceuticals (SXTP) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.05, compared to a current price of $1.71 — trading 16.6% below its estimated fair value. The current Days Inventory is 831.86, which is 106% above median its 10-year median of 404.67 and 352.4% above the Biotechnology industry median of 183.88. 60 Degrees Pharmaceuticals' overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For 60 Degrees Pharmaceuticals (SXTP), the current Days Inventory is 831.86 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 60 Degrees Pharmaceuticals (SXTP) Overvalued in 2026?
Based on GuruFocus' analysis, 60 Degrees Pharmaceuticals stock appears to be undervalued.
The current stock price of $1.71 is trading 16.6% below its estimated GF Value™ of $2.05.
GuruFocus considers 60 Degrees Pharmaceuticals to be Modestly Undervalued.
Key valuation signals for SXTP:
Days Inventory: 831.86 (106% above median its 10-year median of 404.67)
GF Value™: $2.05 vs. price of $1.71 (16.6% below fair value)
Industry Position: 352.4% above the Biotechnology median (#459 of 638)
No single metric tells the full story. See the SXTP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
44GF Score
Get the complete analysis for SXTP
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SXTP has been successfully added to your 
